医学
单克隆抗体
内科学
CD38
多发性骨髓瘤
肿瘤科
抗体
病毒学
癌症研究
免疫学
川地34
干细胞
生物
遗传学
作者
Gary J. Schiller,Brea Lipe,Nizar J. Bahlis,Sascha A. Tuchman,William Bensinger,Heather J. Sutherland,Suzanne Lentzsch,Muhamed Baljević,Darrell White,Rami Kotb,Christine I. Chen,Adriana Rossi,Noa Biran,Richard LeBlanc,Sebastian Grosicki,Maurizio Martelli,Eberhard Gunsilius,Ivan Špıčka,Don A. Stevens,Thierry Façon
标识
DOI：10.1016/j.clml.2023.06.001
摘要
Selinexor-based regimens may offer effective and well-tolerated therapy to patients with relapsed and/or refractory MM who had disease previously exposed or refractory to αCD38 mAb therapy and could help address the unmet clinical need in these high-risk patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
GingerF
OK
fantasy
奋斗易真
Nole
Copyright
斯文钢笔
不潮薯饼
Zephyrite
初景
划子
斯文的初蝶
小小牛马
无极微光
14and15
儒雅的板栗
潇洒的惋清
Zzzz
老胡
皖公网安备34019202002308
